145 related articles for article (PubMed ID: 22819798)
1. Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24 allele.
Wang Y; Sun M; He M; Cui H; Zhang J; Shi L; Wang W; Xu W; Gao B; Ding J
Microb Pathog; 2012 Sep; 53(3-4):162-7. PubMed ID: 22819798
[TBL] [Abstract][Full Text] [Related]
2. Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs.
Mimura K; Kono K; Southwood S; Fikes J; Takahashi A; Miyagawa N; Sugai H; Fujii H
Cancer Immunol Immunother; 2006 Nov; 55(11):1358-66. PubMed ID: 16435129
[TBL] [Abstract][Full Text] [Related]
3. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.
Liu J; Wu P; Gao F; Qi J; Kawana-Tachikawa A; Xie J; Vavricka CJ; Iwamoto A; Li T; Gao GF
J Virol; 2010 Nov; 84(22):11849-57. PubMed ID: 20844028
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis.
Li D; Dou Z; Wu Y; Qi Y; Chen J; Gao Y
Protein Pept Lett; 2020; 27(11):1141-1150. PubMed ID: 32370703
[TBL] [Abstract][Full Text] [Related]
5. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.
Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T
Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.
Akiyama Y; Komiyama M; Nakamura Y; Iizuka A; Oshita C; Kume A; Nogami M; Miyata H; Ashizawa T; Yoshikawa S; Kiyohara Y; Yamaguchi K
Cancer Immunol Immunother; 2012 Dec; 61(12):2311-9. PubMed ID: 22707303
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.
Yamaguchi H; Tanaka F; Ohta M; Inoue H; Mori M
Clin Cancer Res; 2004 Feb; 10(3):890-6. PubMed ID: 14871964
[TBL] [Abstract][Full Text] [Related]
8. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
[TBL] [Abstract][Full Text] [Related]
9. Cross-allele cytotoxic T lymphocyte responses against 2009 pandemic H1N1 influenza A virus among HLA-A24 and HLA-A3 supertype-positive individuals.
Liu J; Zhang S; Tan S; Yi Y; Wu B; Cao B; Zhu F; Wang C; Wang H; Qi J; Gao GF
J Virol; 2012 Dec; 86(24):13281-94. PubMed ID: 23015716
[TBL] [Abstract][Full Text] [Related]
10. Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.
Suda T; Tsunoda T; Daigo Y; Nakamura Y; Tahara H
Cancer Sci; 2007 Nov; 98(11):1803-8. PubMed ID: 17784873
[TBL] [Abstract][Full Text] [Related]
11. Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles.
Li L; Yang B; Yu S; Zhang X; Lao S; Wu C
PLoS One; 2013; 8(12):e82196. PubMed ID: 24349220
[TBL] [Abstract][Full Text] [Related]
12. A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells.
Miyagawa N; Kono K; Mimura K; Omata H; Sugai H; Fujii H
Oncology; 2006; 70(1):54-62. PubMed ID: 16446550
[TBL] [Abstract][Full Text] [Related]
13. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-A24-binding peptides of Mycobacterium tuberculosis derived proteins with beta 2m linked HLA-A24 single chain expressing cells.
Ding J; Wang Y; Cheng T; Chen X; Gao B
Immunol Invest; 2010 Jan; 39(2):103-13. PubMed ID: 20136618
[TBL] [Abstract][Full Text] [Related]
15. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.
Kuzushima K; Hayashi N; Kimura H; Tsurumi T
Blood; 2001 Sep; 98(6):1872-81. PubMed ID: 11535524
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.
Comber JD; Karabudak A; Huang X; Piazza PA; Marques ET; Philip R
Hum Vaccin Immunother; 2014; 10(12):3531-43. PubMed ID: 25668665
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy.
Imahashi N; Nishida T; Ito Y; Kawada J; Nakazawa Y; Toji S; Suzuki S; Terakura S; Kato T; Murata M; Naoe T
Mol Immunol; 2013 Dec; 56(4):399-405. PubMed ID: 23911395
[TBL] [Abstract][Full Text] [Related]
18. Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.
Liu SD; Su J; Zhang SM; Dong HP; Wang H; Luo W; Wen Q; He JC; Yang XF; Ma L
J Cell Mol Med; 2016 Sep; 20(9):1718-28. PubMed ID: 27072810
[TBL] [Abstract][Full Text] [Related]
19. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
Kurokohchi K; Arima K; Nishioka M
J Hepatol; 2001 Jun; 34(6):930-5. PubMed ID: 11451179
[TBL] [Abstract][Full Text] [Related]
20. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
